Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation.

Jenkinson C, Petroczi A, Barker J, Naughton DP.

Steroids. 2012 May;77(6):691-5. doi: 10.1016/j.steroids.2012.02.023. Epub 2012 Mar 11.

PMID:
22429924
2.

Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.

Sten T, Finel M, Ask B, Rane A, Ekström L.

Steroids. 2009 Nov;74(12):971-7. doi: 10.1016/j.steroids.2009.07.004. Epub 2009 Jul 28.

PMID:
19643121
3.

Red wine and component flavonoids inhibit UGT2B17 in vitro.

Jenkinson C, Petroczi A, Naughton DP.

Nutr J. 2012 Sep 7;11:67. doi: 10.1186/1475-2891-11-67.

4.

UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly.

Sten T, Bichlmaier I, Kuuranne T, Leinonen A, Yli-Kauhaluoma J, Finel M.

Drug Metab Dispos. 2009 Feb;37(2):417-23. doi: 10.1124/dmd.108.024844. Epub 2008 Nov 20.

5.

UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse.

Okano M, Ueda T, Nishitani Y, Kano H, Ikekita A, Kageyama S.

Drug Test Anal. 2013 Mar;5(3):166-81. doi: 10.1002/dta.1394. Epub 2012 Aug 9.

PMID:
22887913
6.

Effects of Dietary Components on Testosterone Metabolism via UDP-Glucuronosyltransferase.

Jenkinson C, Petroczi A, Naughton DP.

Front Endocrinol (Lausanne). 2013 Jul 8;4:80. doi: 10.3389/fendo.2013.00080. eCollection 2013.

7.

Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes.

Bauman JN, Goosen TC, Tugnait M, Peterkin V, Hurst SI, Menning LC, Milad M, Court MH, Williams JA.

Drug Metab Dispos. 2005 Sep;33(9):1349-54. Epub 2005 Jun 24.

8.

Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.

Miners JO, Bowalgaha K, Elliot DJ, Baranczewski P, Knights KM.

Drug Metab Dispos. 2011 Apr;39(4):644-52. doi: 10.1124/dmd.110.037036. Epub 2011 Jan 18.

9.

Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.

Anielski P, Simmchen J, Wassill L, Ganghofner D, Thieme D.

Drug Test Anal. 2011 Oct;3(10):645-51. doi: 10.1002/dta.332. Epub 2011 Sep 19.

PMID:
21928278
10.

[Testosterone metabolism and doping test results].

Laczmański Ł, Medraś M.

Endokrynol Pol. 2009 Jan-Feb;60(1):58-62. Review. Polish.

PMID:
19224506
12.

Non-steroidal anti-inflammatory drugs do not influence the urinary testosterone/epitestosterone glucuronide ratio.

Lundmark J, Gårevik N, Thörngren JO, Garle M, Ekström L, Rane A, Schulze JJ.

Front Endocrinol (Lausanne). 2013 May 16;4:51. doi: 10.3389/fendo.2013.00051. eCollection 2013.

13.

Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities.

Mohamed ME, Frye RF.

Drug Metab Dispos. 2011 Sep;39(9):1522-8. doi: 10.1124/dmd.111.039602. Epub 2011 Jun 1.

14.

The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.

Swanson C, Mellström D, Lorentzon M, Vandenput L, Jakobsson J, Rane A, Karlsson M, Ljunggren O, Smith U, Eriksson AL, Bélanger A, Labrie F, Ohlsson C.

J Clin Endocrinol Metab. 2007 Dec;92(12):4878-82. Epub 2007 Aug 14.

PMID:
17698910
15.

Discordant genotyping results using DNA isolated from anti-doping control urine samples.

Choong E, Schulze JJ, Ericsson M, Rane A, Ekström L.

Drug Test Anal. 2017 Jul;9(7):994-1000. doi: 10.1002/dta.2103. Epub 2016 Nov 4.

PMID:
27706926
16.

Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.

Schulze JJ, Lundmark J, Garle M, Skilving I, Ekström L, Rane A.

J Clin Endocrinol Metab. 2008 Jul;93(7):2500-6. doi: 10.1210/jc.2008-0218. Epub 2008 Mar 11.

PMID:
18334593
17.

In vitro evaluation of the effects of anti-fungals, benzodiazepines and non-steroidal anti-inflammatory drugs on the glucuronidation of 19-norandrosterone: implications on doping control analysis.

Palermo A, Alessi B, Botrè F, de la Torre X, Fiacco I, Mazzarino M.

Drug Test Anal. 2016 Sep;8(9):930-9. doi: 10.1002/dta.1897. Epub 2015 Oct 20.

PMID:
26480899
18.

Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.

Bélanger A, Hum DW, Beaulieu M, Lévesque E, Guillemette C, Tchernof A, Bélanger G, Turgeon D, Dubois S.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):301-10. Review.

PMID:
9699884
19.

Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.

Schulze JJ, Lorentzon M, Ohlsson C, Lundmark J, Roh HK, Rane A, Ekström L.

Pharmacogenet Genomics. 2008 Jun;18(6):477-85. doi: 10.1097/FPC.0b013e3282fad38a.

PMID:
18496127
20.

Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.

Zhu AZ, Cox LS, Ahluwalia JS, Renner CC, Hatsukami DK, Benowitz NL, Tyndale RF.

Pharmacogenet Genomics. 2015 May;25(5):263-9. doi: 10.1097/FPC.0000000000000135.

Supplemental Content

Support Center